TGA
- Status: likely_approved
🇦🇺 Bcmaxcd3 in Australia
Bcmaxcd3 (TECLISTAMAB) regulatory status in Australia.
Marketing authorisations
TGA
- Status: likely_approved
Bcmaxcd3 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Australia
Frequently asked questions
Is Bcmaxcd3 approved in Australia?
Yes. TGA has authorised it; TGA has authorised it.
Who is the marketing authorisation holder for Bcmaxcd3 in Australia?
Johnson & Johnson is the originator. The local marketing authorisation holder may differ — check the official source linked above.